3
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Treatment of chloroquine-resistant malaria in monkeys with a drug combination that reverses resistance in vitro

, , &
Pages 467-473 | Received 19 Jul 1991, Accepted 01 Jun 1992, Published online: 15 Nov 2016

REFERENCES

  • Basco, L. K. & Le Bras, J. (1990). Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 479–481.
  • Bitonti, A. J., Sjoerdsma, A., McCann, P. P., Kyle, D. E., Oduola, A. M. J., Rossan, R. N., Milhous, W. K. & Davidson, D. E. (1988). Reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum by desipramine. Science, 242, 1301–1303.
  • Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M. & Pastan, I. (1987). Expression of a multi drug-resistance gene in human tumors and tissues. Proceedings of the National Academy of Science of the United States of America, 87, 265–269.
  • Gottesman, M. M. & Pastan, I (1988). The multidrug transporter, a double-edged sword. Journal of Biological Chemistry, 263, 12136–12169.
  • Gros, P., Ben-Yeriah, Y., Croop, J. & Housman, D. E. (1986). Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature, 323, 728–731.
  • Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M. J., Martin, S. K., Milhous, W. K. & Schlesinger, P. H. (1987). Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science, 238, 1283–1285.
  • Kyle, D. E., Oduola, A. M. J., Martin, S. K. & Milhous, W. K. (1990). Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine and quinidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 474–478.
  • Martin, S. K., Oduola, A. M. J. & Milhous, W. K. (1987). Reversal of chloroquine resistance in P. falciparum by verapamil. Science, 235, 899–901.
  • Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. & Pan, X.-Q. (1989). Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet, i, 334–335.
  • Schmidt, L. H. (1978). P. falciparum and P. vivax in the owl monkey (Aotus trivirgatus) 1. The course of untreated infections. American Journal of Tropical Medicine and Hygiene, 27, 671–702.
  • Taylor, D. W. & Siddequi, W. A. (1979). Susceptibility of owl monkeys to Plasmodium falciparum infection in relation to location of origin, phenotype, and karyotype. Journal of Parasitology, 65, 267–271.
  • Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I. & Willingham, M. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissue. Proceedings of the National Academy of Science of the United States of America, 84, 7735–7738.
  • Ueda, K., Cardarelli, C., Gottesman, M. M. & Pastan, I. (1987). Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin and vinblastine. Proceedings of the National Academy of Science of the United States of America, 84, 3004–3008.
  • Watt, G., Long, G. W., Grogl, M. & Martin, S. K. (1990). Reversal of drug resistant falciparum malaria by calcium antagonists: potential for host cell toxicity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 187–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.